Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5637412 | 1.00 | HTR7 (0.47) | HTR7HSD11B1HRH3POLBNAMPT | |
| SCHEMBL5637493 | 0.87 | CHRNB2 (0.49) | POLBALDH1A1 | |
| SCHEMBL5636471 | 0.87 | CHRNB2 (0.49) | POLBALDH1A1 | |
| SCHEMBL15359350 | 0.86 | HTR7 (0.59) | HTR7HSD11B1HRH3POLBGAA | |
| SCHEMBL13709400 | 0.85 | SPHK2 (0.47) | HRH3POLBHPGDALDH1A1 | |
| SCHEMBL2344483 | 0.84 | SPHK2 (0.50) | HRH3GAAHPGDALDH1A1 | |
| SCHEMBL7429241 | 0.81 | ALDH1A1 (0.46) | HTR7HSD11B1HRH3POLBGAA | |
| SCHEMBL8252500 | 0.81 | ALDH1A1 (0.60) | HSD11B1HRH3POLBGAAHPGD | |
| SCHEMBL8242997 | 0.81 | ALDH1A1 (0.60) | HSD11B1HRH3POLBGAAHPGD | |
| SCHEMBL14498799 | 0.81 | ALDH1A1 (0.60) | HSD11B1HRH3POLBGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| EP-1192165-B1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2004-09-22 | — | — | EP | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |